Elite Pharma Consulting ApS: Financial statements 2025
CVR: 45367673
Source: annual report 2025, Danish Business Authority
29/01/2025 – 31/12/2025
Elite Pharma Consulting ApS (CVR 45367673) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 2,043,362 and a net result of DKK 1,341,615. Equity in the 2025 report amounted to DKK 1,381,615. The solvency ratio was 68.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 2,043,362
- Profit/Loss
- DKK 1,341,615
- Equity
- DKK 1,381,615
- Total Assets
- DKK 2,008,819
- Employees
- 1
Official annual report
How creditworthy is Elite Pharma Consulting ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of January 29, 2025, Khalilallah Wali Mohammad is registered as director of Elite Pharma Consulting ApS.
As of January 29, 2025, Khalilallah Wali Mohammad is registered as an owner of Elite Pharma Consulting ApS with an ownership share of 100%.
Elite Pharma Consulting ApS was founded on January 29, 2025.
About Elite Pharma Consulting ApS
Elite Pharma Consulting ApS is a Danish company of the type Anpartsselskab based in Skovlunde, founded in 2025. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The management consists of Khalilallah Wali Mohammad. The company is owned by Khalilallah Wali Mohammad. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK 2,043,362 and a net result of DKK 1,341,615. Equity in the 2025 report amounted to DKK 1,381,615.